Rheumatoid arthritis is a painful and disabling autoimmune disease that affects more than 1% of people worldwide. In the ...

The cannabinoid industry is transitioning from early-stage exploration to scientifically validated, regulatory-backed ...

Among patients with mNSCLC receiving ICIs, overall survival was similar between those with vs without coexisting RA.

EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial ...

This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.

GLP-1 receptor agonists may significantly reduce the risk for cardiovascular events in patients with rheumatoid arthritis ...

netvision.net.il Objective: To assess the efficacy and safety of vaccination against influenza virus in patients with rheumatoid arthritis, with special emphasis on the effect of disease modifying ...

Phase 1 data for Spyre Therapeutics, Inc.'s SPY002 & SPY072 show promise in autoimmune treatments. Advancing to Phase 2 ...

Treatment for arthritis depends on the underlying cause. In some cases, physical therapy and surgery are needed. However, arthritis management often involves medication. A common option that’s ...

Turmeric is a spice with antioxidant and anti-inflammatory properties. It may help to treat various types of pain, including ...

Objective To examine the course of interstitial lung disease associated with rheumatoid arthritis (RA-ILD) in France on treatment with Janus kinase inhibitors (JAKis) using the MAJIK-SFR registry.